ALDH3A1 and neoplasm: To investigate how the varying ALDH3A1 expression levels might affect the carcinogenicity state, we opted to employ tumor cell lines, i.e., NSCLC HCC4006, and melanoma cells WM266-4 and MEL4478D in gain or loss of function studies.